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A B S T R A C T
Geriatric hip fractures (GHP) are the major problem in the geriatric traumatology and it is estimated that treatment
of GHF will spend a large amount of health care resources1–5. The aim of this retrospective study was to compare differ-
ences in incidence of operatively treated patients with GHF, type of treatment depending of the type of fracture, early post-
operative mortality, length of stay and costs of used implants within a 10 years period. Surgically treated 2478 patients,
older than 65 years with hip fractures were included in the study. Patients were grouped according to the type of fracture
(femoral neck fracture or intertrochanteric femoral fracture) and used implant. Results showed increasing trend in GHF
in our County in the last 10 years. There was a shifting trend in used implants, and new surgical techniques were used
more commonly in the last few years. In observed period there were no significant changes in revision surgery and length
of hospital stay. The mortality decreased, especially in males, but generally it was not in correlation with used implant.
At the 10-years period increase in patients with GHF of 179% was followed with 4 time higher increase in implant prices.
Present reimbursement in health care system does not calculate the difference of implant costs in hospital expenses, there-
fore proper usage of modern implants and careful planning in the treatment of GHF is necessary.
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Introduction
Hip fractures are the major problem in the geriatric
traumatology. These fractures are the most devastating
consequence of osteoporosis and the major source of mor-
bidity and mortality in elderly patients1,2. Patients who
survive usually need long-term medical care because of
prolonged disability2. Majority of these patients sustai-
ned low-energy injury during fall from sitting or stand-
ing position1. Weakened reflexes to cushion the impact
also have the important role in mechanism of these
injuries3. From the patient’s point of view, a hip fracture
has a strong social and existential impact4. In the future
geriatric hip fractures (GHF) will grow to be a major
public health problem and treatment of these patients
will spend a large amount of health and social care
resources5,6. It is estimated that osteoporosis contributes
to 90% of GHF in women and 80% in men3. Therefore it
is necessary to establish a program with preventive mea-
sures, especially for older patients with previous osteo-
porotic fracture2,7,8.
The change of surgical technique, improvement of im-
plants, advances in anesthesiology, and perioperative
multidisciplinary approach to the patient improved the
overall result of treatment, but high incidence of compli-
cations and mortality still significantly influences the
outcome9–11. Financial situation in Croatian health care
system was improving. Today, modern implants are avai-
lable at our department and patients with GHF were
treated according to the modern principles of geriatric
traumatology9. Data about economic impact of GHF in
Croatians health system are unknown. Lack of trauma
register and systematic evidence of GHF in Croatia dis-
able us to provide the real significance of this problem in
our community12. University Hospital Rijeka is a single
acute hospital in Primorsko-goranska County where vast
majority of patients with GHF are treated at the Depart-
ment of Traumatology. Therefore, hospital records on
GHF from University Hospital Rijeka will provide good
insight into population of the County.
199
Received for publication January 10, 2010
The aim of this retrospective study was to analyze the
incidence of operatively treated patients with GHF and
type of treatment depending of the type of fracture. Out-
come was assessed with early postoperative mortality,
rate of revision surgery and length of stay (LOS) in last
10 years. Results were compared with costs of used im-
plants.
Patients and Methods
Within a ten year period from 1999 to 2008 there were
total of 15,697 surgically treated patients at the Depart-
ment of Traumatology, University Hospital Rijeka, Cro-
atia. In this period 2,478 patients older than 65 years
with GHF were surgically treated. Non-operatively trea-
ted patients were excluded from this study. Patients with
GHF were grouped according to the type of fracture:
intracapsular femoral neck fracture (FNF) of extracap-
sular intertrochanteric femoral fracture (IFF). Data on
used implants were documented for specific type of in-
jury as well as the price of used implant. Results of the
treatment were presented in in-hospital mortality rate,
rate of revision of surgery and LOS.
Total cost of implants was calculated from the num-
ber of used implants and present prices from contracts
with hospital suppliers. The price was calculated in EUR
according to the Croatian National Bank exchange rate,
middle rate at the day of calculation13.
Incidence was calculated for the number of citizens
according to the Census of Population, Households and
Dwellings 31st March 2001, taking into account that the
census before that was in 1991 and the war in Croatia
was between 1991 and 1995. The population in 1999 was
more likely to be similar to the population of 200114.
Statistical analysis
Descriptive analysis of data was performed using de-
scriptive statistics. Bivariate correlation analyses using
nonparametric Spearsons test were performed between
groups of patients with different types of GHF and treat-
ment outcomes. A p-value of <0.05 was considered sig-
nificant. Analyses were carried out by SPSS 15.0 (SSPS
Inc., Chicago, IL, USA) statistical software package.
Results
In the period from 1999 to 2008 total number of surgi-
cally treated patients with GHF raised from 176 in 1999
to 315 in 2008 (increase of 1.8 times). Proportion of sur-
gically treated patients with GHF comparing to total
number of surgically treated patients rose from 14.1% to
19.4% (Figure 1). Calculated incidence of GHF crude rate
per 1000 inhabitants shows increase with constant ratio
between females and males (Figure 2). Incidence of GHF
was almost doubled in 10 years, from 3.56 to 6.37 where
incidence in female population is higher as expected
Mean (95% CI) = 6.4350 (5.4310–7.4390), SD=1.40347,
and incidence in male population lower, Mean (95% CI) =
2.9000 (2.3735–3.4265), SD=0.73598. Ratio between FNF
and IFF did not change during whole period (Figure 3).
In 2008 the increase in use of compression hip screw
(CHS) and intramedullary nail (IMN) instead of angled
blade plate (ABP) for treatment of IFF was observed (Ta-
ble 1). Change was also observed in the treatment of FNF


































Fig. 2. Trend in incidence by gender of geriatric hip fractures,






































Fig. 3. Percentage of patients with FNF and ITF in 10 year

















Fig. 1. Proportion of surgically treated GHF and other surgically
treated patients, GHF – geriatric hip fractures.
with trend towards total hip arthroplasty (THA) versus
hemiarthroplasty (HA) in last years (Table 2). One year
in-hospital mortality among surgically treated patients
with GHP decreased from 7.4% in 1999 to 3.4% in 2000
(Figure 4). Mortality rate was higher in male patients
comparing to females. The rate of revision surgery in
both groups was low and it did not significantly change
in 10 years period (Table 1, 2). Average LOS for surgi-
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TABLE 1











1999. 72 (97.30) 0 (0.00) 0 (0.00) 2 (2.00) 0 (0.00)
2000. 85 (97.70) 0 (0.00) 2 (2.30) 0 (0.00) 1 (1.15)
2001. 83 (94.32) 0 (0.00) 4 (4.55) 1 (1.14) 0 (0.00)
2002. 107 (90.68) 0 (0.00) 2 (1.69) 9 (7.63) 5 (4.24)
2003. 121 (98.37) 0 (0.00) 0 (0.00) 2 (1.63) 7 (5.69)
2004. 134 (91.16) 3 (2.04) 0 (0.00) 10 (6.80) 6 (4.08)
2005. 119 (97.54) 0 (0.00) 0 (0.00) 3 (2.46) 1 (0.82)
2006. 132 (96.35) 1 (0.73) 4 (2.92) 0 (0.00) 2 (1.46)
2007. 140 (94.59) 3 (2.03) 1 (0.68) 4 (2.70) 2 (1.35)
2008. 93 (65.96) 16 (11.35) 23 (16.31) 9 (6.38) 2 (1.42)
IFF – intertrochanteric femoral fracture, ABP – angled blade plate, CHS – compression hip screw, IMN – imtramedullary nail,
HA – hemiarthroplasty
TABLE 2









1999. 101 (99.02) 1 (0.98) 0 (0.00) 3 (2.94)
2000. 88 (100.00) 0 (0.00) 0 (0.00) 5 (5.68)
2001. 75 (89.29) 9 (10.71) 0 (0.00) 2 (2.38)
2002. 117 (96.69) 4 (3.31) 0 (0.00) 1 (0.83)
2003. 113 (90.40) 12 (9.60) 0 (0.00) 2 (1.60)
2004. 113(86.92) 17(13.08) 0 (0.00) 8 (6.15)
2005. 114 (75.00) 38 (25.00) 0 (0.00) 3 (1.97)
2006. 140 (85.89) 11(6.75) 12 (7.36) 5 (3.07)
2007. 132 (85.71) 22 (14.29) 0 (0.00) 4 (2.60)





































































Fig. 5. Trend in average length of stay (days).
cally treated patients with GHF did not change in the all
10 years Mean (95% CI) = 13.220 (12.232– 14.208), SD
= 1.3807 (Figure 5). Total implants cost showed in-
crease from 19,026 to 80,969 EUR per year (Figure 6).
Correlation between different techniques and im-
plants used showed significantly lower mortality with
CHS and uncemented THA (Table 3). No difference was
observed in correlation between implants used for treat-
ment of FNF and revision surgery (Table 4), but in the
surgical stabilization of IFF with ABP has higher revi-
sion rate than other implants (Table 5). Average LOS
was not in correlation with different type of implants
(Table 6).
Discussion
Increased number of surgically treated patients with
GHF in past decade is expected because of the burden of
osteoporosis and aging population of Primorsko-goran-
ska County where 16.2% of population is older then
655,7,10. However some epidemiological analyses from dif-
ferent countries show different trends in incidence of hip
fractures15–17. According to other researchers, by the
year of 2050 expected increase in incidence of hip frac-
tures will be 310% in men and 240% in women18. If we
follow this prognosis the total number of GHF in 2050
will raise up to 810 patients per year. This number is very
important factor for future calculation and future devel-
opment of trauma department and other necessary facili-
ties in our hospital. Several authors showed that in-hos-
pital mortality after hip fracture was approximately
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TABLE 3
CORRELATION BETWEEN DIFFERENT TYPES OF IMPLANTS
AND MORTALITY DUE TO GHF








GHF – geriatric hip fracture, HA – hemiarthroplasty, FNF – fe-
moral neck fracture, THA – total hip arthroplasty, UTHA – un-
cemented total hip arthroplasty, ABP – angled blade plate, CHS
– compression hip screw, IMN – imtramedullary nail, IFF – in-
tertrochanteric femoral fracture
* Spearman’s rho R – correlation coefficient






































Fig. 6. Costs of implants within 10 year period, FNF – femoral
neck fractures, IFF – intertrochanteric femoral fractures, GHF –
geriatric hip fractures.
TABLE 4
CORRELATION BETWEEN DIFFERENT TYPES OF IMPLANTS
AND REVISION SURGERY DUE TO FNF




FNF – femoral neck fracture, HA – hemiarthroplasty, THA – to-
tal hip arthroplasty, UTHA – uncemented total hip arthroplasty
* Spearman’s rho R – correlation coefficient
** p<0.05 was considered significant
TABLE 5
CORRELATION BETWEEN DIFFERENT TYPES OF IMPLANTS
AND REVISION SURGERY DUE TO IFF





IFF – intertrochanteric femoral fracture, ABP – angled blade
plate, CHS – compression hip screw, IMN – imtramedullary nail,
HA – hemiarthroplasty
* Spearman’s rho R – correlation coefficient
** p<0.05 was considered significant
TABLE 6
CORRELATION BETWEEN DIFFERENT TYPES OF IMPLANTS
AND AVERAGE LENGTH OF STAY DUE TO GHF








GHF – geriatric hip fracture, HA – hemiarthroplasty, FNF – fe-
moral neck fracture, THA – total hip arthroplasty, UTHA – un-
cemented total hip arthroplasty, ABP – angled blade plate, CHS
– compression hip screw, IMN – intramedullary nail, IFF – in-
tertrochanteric femoral fracture; * Spearman’s rho R – correla-
tion coefficient; ** p<0.05 was considered significant
3%11,19,20. Reported 30-day mortality was 5.2%10. Our
data in the last year of observation showed similar mor-
tality in-hospital rate of 3.49%. Higher mortality rate
was observed in males than females, and this was in ac-
cordance to results reported by Stone et al.20. More de-
tailed analysis of patient’s age and comorbidity should be
done for future analysis. These results suggest that male
patients with GHF should be carefully assessed before
surgery and carefully monitored for postoperative com-
plications21.
The mean LOS in recent studies was from 5.6 to 10.27
days10,11. LOS in our study varies from 11.1 to 16 days
and trend to be shorter. Although the change of implants
and surgical technique was made to allow early mobiliza-
tion and weight bearing, the overall LOS did not de-
crease dramatically. Possible reason for longer in-hospi-
tal stay was that management of co-morbidities and
complications that influenced the duration of treatment,
as well as engagement and possibilities for treatment by
other health professionals such as nurses or physiothera-
pists. Reported results from the literature show that
86.3% of GHF patients have one or more comorbidities
and 41.2% had at least one in-hospital complication11.
The main goal of GHP management is early mobiliza-
tion, prevention of bed-ridden complications and return
to functional activities for independent living9. To achie-
ve this goal surgical implant for GHP were changed in
the past few decades. ABP were replaced, first with slid-
ing CHS, than with IMN to allow immediate full weight
bearing after surgical stabilization of IFF22–24. Common
expert opinion that IMN fixation for IFF is superior to
sliding CHS and side plate is not well proven24. Despite of
a lack of scientific evidence that IMN is superior to slid-
ing CHS, most of the trauma and orthopedic surgeons in
nowadays are using intramedullary fixation for treat-
ment of IFF24–27. This change resulted in higher expenses
because of two to four times higher prices of IMN28. An
extensive geographic variation in the use of differentially
reimbursed IFF procedures persists in the United States,
and these variations are not the consequence of pa-
tient-related factors. The question why surgeons select
the device on the basis of non-patient factors is not
explained29.
Sliding CHS and side plate fixation resulted in fewer
complications rate compared with intramedullary nail
fixation24,25. Geriatric patients managed with IMN had
slightly greater rate of revision surgery in the first year,
an increased rate of hospital stay and higher hospital
cost in comparison with patients treated with sliding
CHS26,27. Our study showed that fracture fixation with
ABP correlated with higher rate of revision surgery. It
can be explained with large number of treated patients
and fact that the most of the unstable fractures and
»worst cases« were treated with this implant. Currently,
there are some published articles with favorable results
in the treatment of unstable pertrochanteric fractures
with 95 ABP30,31. This implant is abandoned in most of
the institutions even its price is very low in comparison
to the other implants.
The number of patients treated with CHS in our
study was very low and this difference could be not ex-
plained by medical reasons20. Shifting trend to use more
CHS and IMN in the treatment of IFF at 2008 was ac-
cording to expert opinion and modern trauma care. Ap-
propriate choose of fixation technique and implant, de-
pending on fracture and patient personality, should be
made to allow early weight bearing and immediate reha-
bilitation program.
Hip replacement in FNF management has changed
towards THA instead HA which remains a treatment of
choice for very old patients with short life expectancy
and very low functional demands32–34. THA after intra-
capsular FNF shows superior results than HA32–34. Jain
et al. reported greater utilization of HA and decrease in
utilization of THA comparing a period 1990 to 1993 to
period from 1998 to 2001 in United States35. This trend
is also shown in our study. Advantages of THA for older
patients are obvious, and THA is a treatment of choice
for elderly, mobile, independent patients32,33. Uncemen-
ted THA should be used for younger patients36. Our re-
sults showed significant increase in the uncemented
THA in last years, and there is no medical explanation to
use almost six times more uncemented than cemented
THA in 2008.
Additional research is necessary to establish a proper
indication for bipolar HA, because implants are more ex-
pensive than unipolar HA, and there is no difference in
outcome after bipolar or unipolar HA10,37. Current data
from literature suggest that use of unipolar implants for
HA could save healthcare expenses, without jeopardizing
patient’s outcome10. In our study low numbers of pa-
tients were treated with bipolar HA. Additionally, almost
four times higher price of bipolar prosthesis suggests
that use of this implant should be abandoned because
there is no benefit for the patient.
In the United States changing of fixation strategy in
IFF has resulted in higher implant cost and surgeon fees
with no improvement in patient outcome24,28. United
States Federal Register reimbursed an average of $272
more for IMN then for plate-and- screw device38. Present
reimbursement of hospital costs in Croatia does not cal-
culate difference in implant prices39–45. Therefore the
shift in the treatment with modern and more expensive
implants should be carefully monitored and changed
only because of medical indications and better patient’s
outcome. In implant cost analysis there was significant
increase in implant prices in last years. In observed pe-
riod total costs for implants have risen up from 19,000 to
more than 80,000 EUR for year. This economic aspect
should be carefully monitored to avoid extreme hospital
expenses for implants without proven benefits for the pa-
tients. Recently introduced reimbursements in Croatian
health care system calculate the hospital expenses ac-
cording to the diagnosis and presence of complications,
but not of type of surgery or used implant39–45.
Proper usage of modern implants and careful plan-
ning in the treatment of GHF is necessary to improve the
patients’ outcome. Furthermore, rational care of finan-
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cial resources is necessary because of the burden of the
GHF. Future analysis of the GHF epidemiology and treat-
ment is needed to improve strategies in prevention, qual-
ity of care and economic efficiency of GHF manage-
ment40.
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PRIJELOMI KUKA U STARIJOJ DOBI – ANALIZA KROZ 10 GODINA
S A @ E T A K
Prijelomi kuka u starijoj dobi su najve}i problem u gerijatrijskoj traumatologiji i mo`e se o~ekivati da }e se na lije-
~enje ovih prijeloma u budu}nosti utro{iti velika koli~ina sredstava iz zdravstvenih fondova. Cilj ove retrospektivne
studije bio je usporediti razlike u: incidenciji operativno lije~enih bolesnika s prijelomom kuka u starijoj dobi, na~inu
lije~enja ovisno o tipu prijeloma, ranom poslijeoperacijskom mortalitetu, du`ini trajanja hospitalizacije i cijeni kori{te-
nih implantata, u razdoblju od 10 godina. U studiju je uvr{teno 2478 pacijenata, starijih od 65 godina, s prijelomom u
podru~ju kuka koji su razvrstani s obzirom na tip prijeloma (prijelom u podru~ju vrata bedrene kosti ili prijelom u
podru~ju trohanterne regije bedrene kosti). Retultati su pokazali porast incidencije prijeloma kod bolesnika starije dobi
u na{oj @upaniji. Prisutan je trend kori{tenja novijih implantata u posljednjim godinama. U analiziranom razdoblju nije
uo~ena zna~ajnija promjena u broju reoperacija i du`ini hospitalizacije. Mortalite je bio u opadanju, naro~ito u mu{koj
populaciji, ali ukupno gledano nije bio u korelaciji s tipom kori{tenog implantata. U desetogodi{njem razdoblju, porast
bolesnika starije dobi s prijelomom kuka od 179% bio je pra}en s 4 puta ve}om cijenom implantata, stoga je u lije~enju
prijeloma kuka kod starijih bolesnika potrebno pravilno indicirati i pa`ljivo planirati upotrebu modernih implantata.
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